Search research articles
Contact Us
Filters
Showing results (241-250 of 368) with videos related to
Page
of 37
Sort By:
Cancer
|
December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma
Ravi D Rao, Shernan G Holtan, James N Ingle, et al.
Frontiers in Immunology
|
July 3, 2026
Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches
Jacqueline A Turner, Marc D'Antonio, Heather N Montane, et al.
Oncoimmunology
|
May 4, 2016
GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses
Serena S Kwek, James Kahn, Samantha K Greaney, et al.
Melanoma Research
|
June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine
Matthew S Block, Vera J Suman, Wendy K Nevala, et al.
American Journal of Lifestyle Medicine
|
December 9, 2024
Cancer and Stress: Understanding the Connections and Interventions
Stacy D D'Andre, Lisa L Ellsworth, Janae L Kirsch, et al.
Frontiers in Immunology
|
February 19, 2025
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Yuan Yao, Yiyi Yan, Vera J Suman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2008
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study
Luis F Porrata, David J Inwards, Stephen M Ansell, et al.
Melanoma Research
|
May 2, 2015
Ipilimumab-induced colitis in patients with metastatic melanoma
Kara M De Felice, Arjun Gupta, Sagar Rakshit, et al.
Leukemia
|
June 22, 2007
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas
L F Porrata, K Ristow, T E Witzig, et al.
Cancer
|
April 8, 2011
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)
Lisa A Kottschade, Vera J Suman, Thomas Amatruda, et al.
Page
of 37
Search research articles
Search
Showing results (241-250 of 368) with videos related to
Sort By:
Page
of 37
Cancer
|
December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma
Ravi D Rao, Shernan G Holtan, James N Ingle, et al.
Frontiers in Immunology
|
July 3, 2026
Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approaches
Jacqueline A Turner, Marc D'Antonio, Heather N Montane, et al.
Oncoimmunology
|
May 4, 2016
GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses
Serena S Kwek, James Kahn, Samantha K Greaney, et al.
Melanoma Research
|
June 24, 2011
Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine
Matthew S Block, Vera J Suman, Wendy K Nevala, et al.
American Journal of Lifestyle Medicine
|
December 9, 2024
Cancer and Stress: Understanding the Connections and Interventions
Stacy D D'Andre, Lisa L Ellsworth, Janae L Kirsch, et al.
Frontiers in Immunology
|
February 19, 2025
Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
Yuan Yao, Yiyi Yan, Vera J Suman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 11, 2008
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study
Luis F Porrata, David J Inwards, Stephen M Ansell, et al.
Melanoma Research
|
May 2, 2015
Ipilimumab-induced colitis in patients with metastatic melanoma
Kara M De Felice, Arjun Gupta, Sagar Rakshit, et al.
Leukemia
|
June 22, 2007
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas
L F Porrata, K Ristow, T E Witzig, et al.
Cancer
|
April 8, 2011
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1)
Lisa A Kottschade, Vera J Suman, Thomas Amatruda, et al.
Page
of 37